FIELD: biotechnology, food processing industry, medicine.
SUBSTANCE: claimed consortium is obtained from bifidus-bacterium strains with excellent superoxide dismutase, antioxidant and antibiotic activity, namely: Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium adolescentis, Bifidobacterium infantis, Bifidobacterium breve. Consortium has superoxide dismutaseactivity not less than 24.9 unit/mg of microbial protein mass. Consortium is able to utilize wide amino acid spectrum and has high antibiotic resistance and increased resistance to aggressive media of gastrointestinal tract.
EFFECT: bifidus-bacterium consortium with increased colony forming activity for manufacturing of products with excellent probiotic and healthy effect.
2 tbl, 5 ex
Authors
Dates
2005-10-10—Published
2004-10-20—Filed